CASP3 and lip and oral cavity carcinoma: EGCG treatment on caspase 3 wild-type oral cancer cell lines has been demonstrated to cause a progressive reduction in mitochondrial activity down to a negligible level; however, apoptosis was not seen in caspase 3 null cells (8).